More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

Cambridge-based Biogen is looking to the growth of its Alzheimer’s drug Leqembi to offset the decline of its multiple ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut could ...

Leaders at Eli Lilly believe heavy investment in the company's manufacturing footprint “sets a high standard that newcomers ...

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Discover why now isn't the time to ...

We imagine something different, a 100 percent online system that's accessible, personalized, and designed around how people ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

Dudum is still the largest individual holder of Hims & Hers' stock, owning about 8 million shares indirectly through various trusts and another 92,313 directly. Together, the stake is worth about $388 ...